Shocking Data Reveals Alarming COVID Vaccine Death Toll in Japan** In a stunning revelation that threatens to upend the narrative surrounding COVID-19 vaccinations, a grassroots ...

New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

In light of recent revelations surrounding a new intranasal COVID-19 vaccine candidate, there is growing concern that the American public is once again being led into potentially dangerous territory ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

In a historic breakthrough for global medicine, Israeli researchers have made a ground-breaking development of the world’s ...

The team from Tel Aviv University developed a vaccine to combat the bacterium that causes the black plague, using the same ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

As of May 2023, the WHO recommends the use of a monovalent XBB.1 descendent lineage, such as omicron XBB.1.5, as the vaccine antigen for COVID-19 vaccines. However, BA.2.86 and its descendent lineages ...

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago. Indeed, if you axed Moderna off your watchlist after the ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...